Global Neurodegenerative Disease Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI640511
- March 18, 2019
- Global
- 93 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Neurodegenerative Disease market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Neurodegenerative Disease market."
Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.
The global Neurodegenerative Disease market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neurodegenerative Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Segment by Regions
North America
Europe
China
Japan
Segment by Type
NMDA
SSRIs
Dopamine Inhibitors
Segment by Application
Parkinsons Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimers Disease
Table of Contents
Executive Summary
1 Neurodegenerative Disease Market Overview
1.1 Product Overview and Scope of Neurodegenerative Disease
1.2 Neurodegenerative Disease Segment by Type
1.2.1 Global Neurodegenerative Disease Production Growth Rate Comparison by Type (2014-2025)
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Neurodegenerative Disease Segment by Application
1.3.1 Neurodegenerative Disease Consumption Comparison by Application (2014-2025)
1.3.2 Parkinson’s Disease
1.3.3 Huntington Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Alzheimer’s Disease
1.4 Global Neurodegenerative Disease Market by Region
1.4.1 Global Neurodegenerative Disease Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Neurodegenerative Disease Market Size
1.5.1 Global Neurodegenerative Disease Revenue (2014-2025)
1.5.2 Global Neurodegenerative Disease Production (2014-2025)
2 Global Neurodegenerative Disease Market Competition by Manufacturers
2.1 Global Neurodegenerative Disease Production Market Share by Manufacturers (2014-2019)
2.2 Global Neurodegenerative Disease Revenue Share by Manufacturers (2014-2019)
2.3 Global Neurodegenerative Disease Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Neurodegenerative Disease Production Sites, Area Served, Product Types
2.5 Neurodegenerative Disease Market Competitive Situation and Trends
2.5.1 Neurodegenerative Disease Market Concentration Rate
2.5.2 Neurodegenerative Disease Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Neurodegenerative Disease Production Market Share by Regions
3.1 Global Neurodegenerative Disease Production Market Share by Regions
3.2 Global Neurodegenerative Disease Revenue Market Share by Regions (2014-2019)
3.3 Global Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Neurodegenerative Disease Production
3.4.1 North America Neurodegenerative Disease Production Growth Rate (2014-2019)
3.4.2 North America Neurodegenerative Disease Production, Revenue, Price ...
| read more...
Related Reports
